Lipoteichoic Acids fromLactobacillus johnsoniiStrain La1 andLactobacillus acidophilusStrain La10 Antagonize the Responsiveness of Human Intestinal Epithelial HT29 Cells to Lipopolysaccharide and Gram-Negative Bacteria
- 1 April 2002
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 70 (4) , 2057-64
- https://doi.org/10.1128/iai.70.4.2057-2064.2002
Abstract
Intestinal epithelial cells (IECs) respond to lipopolysaccharide (LPS) from gram-negative bacteria in the presence of the soluble form of CD14 (sCD14), a major endotoxin receptor. Since sCD14 is also known to interact with gram-positive bacteria and their components, we looked at whether sCD14 could mediate their effects on human IECs. To this end, we examined the production of proinflammatory cytokines following exposure of the IECs to specific gram-positive bacteria or their lipoteichoic acids (LTAs) in the absence and presence of human milk as a source of sCD14. In contrast to LPS fromEscherichia coliorSalmonella enteritidis, neither the gram-positive bacteriaLactobacillus johnsoniistrain La1 andLactobacillus acidophilusstrain La10 nor their LTAs stimulated IECs, even in the presence of sCD14. However, both LTAs inhibited the sCD14-mediated LPS responsiveness of IECs. We have previously hypothesized that sCD14 in human milk is a means by which the neonate gauges the bacterial load in the intestinal lumen and liberates protective proinflammatory cytokines from IECs. The present observations suggest that gram-positive organisms, via their LTAs, temper this response and prevent an exaggerated inflammatory response.Keywords
This publication has 41 references indexed in Scilit:
- A lipoteichoic acid fraction ofEnterococcus hiraeactivates cultured human monocytic cells via a CD14-independent pathway to promote cytokine production, and the activity is inhibited by serum componentsFEMS Immunology & Medical Microbiology, 1998
- The use of probiotics to reinforce mucosal defence mechanismsTrends in Food Science & Technology, 1997
- Receptor-Dependent Mechanisms of Cell Stimulation by Bacterial EndotoxinAnnual Review of Immunology, 1995
- Macrophage Inflammatory Protein-1α Expression in Vivo and in Vitro: The Role of Lipoteichoic AcidClinical Immunology and Immunopathology, 1995
- Regulatory effects of bifidobacteria on the growth of other colonic bacteriaJournal of Applied Bacteriology, 1994
- Peptidoglycan and teichoic acid fromStaphylococcus epidermidisstimulate human monocytes to release tumour necrosis factor-α, interleukin-1β and interleukin-6FEMS Immunology & Medical Microbiology, 1993
- Use of transgenic mice to map cis-acting elements in the intestinal fatty acid binding protein gene (Fabpi) that control its cell lineage-specific and regional patterns of expression along the duodenal-colonic and crypt-villus axes of the gut epithelium.The Journal of cell biology, 1992
- CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding ProteinScience, 1990
- Biochemical characterization of a soluble form of the 53‐kDa monocyte surface antigenEuropean Journal of Immunology, 1986
- Improved Preparation of Lipoteichoic AcidsEuropean Journal of Biochemistry, 1983